Compara mètodes
Revisa els mètodes seleccionats l'un al costat de l'altre; les files que difereixen es ressalten.
| Child Health Questionnaire (CHQ)× | Mòdul PedsQL de Càncer× | |
|---|---|---|
| Camp | Pediatria | Pediatria |
| Família | Process / pipeline | Process / pipeline |
| Any d'origen≠ | 1996 | 2002 |
| Autor original≠ | John M. Landgraf | James W. Varni |
| Tipus≠ | Parent report (primary) and child self-report versions available | Child self-report and parent proxy |
| Font seminal≠ | Landgraf, J. M., Abetz, L., & Ware, J. E. (1996). The CHQ User's Manual. HealthAct. ISBN: 978-0965475303 | Varni, J. W., Burwinkle, T. M., Katz, E. R., Meeske, K., & Dickinson, R. P. (2002). The PedsQL in pediatric cancer: Reliability and validity of the Pediatric Quality of Life Inventory Generic Core Scales, multidimensional fatigue scale, and cancer module. Cancer, 94(7), 2090-2106. DOI ↗ |
| Àlies≠ | CHQ-50, CHQ-28, CHQ-PF28, CHQ-CF87 | PedsQL 3.0 Cancer |
| Relacionats≠ | 4 | 5 |
| Resum≠ | The Child Health Questionnaire is a generic, parent-reported instrument developed by Landgraf et al. in 1996 to measure health-related quality of life in children aged 5–18 years. Unlike disease-specific measures, the CHQ captures broad domains of physical, emotional, social, and school functioning, making it suitable for diverse pediatric populations with or without chronic conditions. The CHQ-50 is the most widely used parent-report form; shorter (CHQ-28) and comprehensive (CHQ-CF87 child + family) versions are also available. | The PedsQL Cancer Module is a 31-item disease-specific instrument developed by Varni et al. in 2002 to measure quality of life in children and adolescents with cancer aged 2–18 years. It captures treatment burden (nausea, vomiting, pain, hair loss), cancer-related worry, cognitive concerns, and emotional and social impacts of diagnosis and treatment. Used alongside the PedsQL Generic Core Scales, it provides comprehensive assessment of both cancer-specific and general health-related quality of life during active treatment, survivorship, and end-of-life care. |
| ScholarGateConjunt de dades ↗ |
|
|